New findings from a landmark clinical trial show that although certain gene variants may predict whether a person will develop age-related macular degeneration (AMD), these genes do not predict patients' responses to Lucentis™ and Avastin™, two medications widely used to treat "wet" AMD.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/b...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/b...